ROL vs SRNE · P/E 41, rev $1.99B vs $385.9K cap
Rollins Inc (ROL) versus Sorrento Therape (SRNE) — a side-by-side from cached financials, not a winner call.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Sorrento Therape (SRNE) is a biotechnology company listed on OTCQB.
Latest reported ROL revenue for 2026-06-30 was $1.99B. Net income was $251.7M. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
SRNE does not have a complete income-statement cache yet.
ROL currently screens at market cap $21.73B and trailing P/E 41.4. SRNE currently screens at market cap $385.9K.
Not investment advice. Open the ROL and SRNE stock pages for the full models.
Not investment advice.